SCHEMBL12031829

SCHEMBL12031829

CO[C@H]1CO[C@H]2[C@@H]1OC[C@@H]2OC

nearest known ligand 0.42

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
BCHE P06276 5/20 0.36
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20082291 1.00 ALDH1A1 (0.42) ALDH1A1BCHEMAPTTHRBLMNA
SCHEMBL17252148 1.00 ALDH1A1 (0.42) ALDH1A1BCHEMAPTTHRBLMNA
SCHEMBL12036588 1.00 ALDH1A1 (0.42) ALDH1A1BCHEMAPTTHRBLMNA
SCHEMBL301881 1.00 ALDH1A1 (0.42) ALDH1A1BCHEMAPTTHRBLMNA
SCHEMBL1368298 1.00 ALDH1A1 (0.42) ALDH1A1BCHEMAPTTHRBLMNA
SCHEMBL19501221 1.00 ALDH1A1 (0.42) ALDH1A1BCHEMAPTTHRBLMNA
SCHEMBL12786632 1.00 ALDH1A1 (0.42) ALDH1A1BCHEMAPTTHRBLMNA
SCHEMBL22627598 1.00 ALDH1A1 (0.42) ALDH1A1BCHEMAPTTHRBLMNA
SCHEMBL20613593 1.00 ALDH1A1 (0.42) ALDH1A1BCHEMAPTTHRBLMNA
SCHEMBL17252155 1.00 ALDH1A1 (0.42) ALDH1A1BCHEMAPTTHRBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399468-A1 BIO-BASED SULFONE COPOLYMERS FREE OF BPA AND BPS SYENSQO SPECIALTY POLYMERS USA, LLC 2023-12-14 US disclosed
US-20230399468-A1 BIO-BASED SULFONE COPOLYMERS FREE OF BPA AND BPS SYENSQO SPECIALTY POLYMERS USA, LLC 2023-12-14 US disclosed
US-11788009-B2 Liquid-crystalline medium for use in a switching element MERCK PATENT GMBH (DE) 2023-10-17 US disclosed
US-11788009-B2 Liquid-crystalline medium for use in a switching element MERCK PATENT GMBH (DE) 2023-10-17 US disclosed
US-11781069-B2 Liquid-crystal medium MERCK PATENT GMBH (DE) 2023-10-10 US disclosed
US-20230313043-A1 OPTICAL COMPONENT MERCK PATENT GMBH (DE) 2023-10-05 US disclosed
US-11760931-B2 Liquid-crystalline medium for use in a switching element MERCK PATENT GMBH (DE) 2023-09-19 US disclosed
US-11760931-B2 Liquid-crystalline medium for use in a switching element MERCK PATENT GMBH (DE) 2023-09-19 US disclosed
US-11667840-B2 Liquid-crystalline medium MERCK PATENT GMBH (DE) 2023-06-06 US disclosed
US-11667840-B2 Liquid-crystalline medium MERCK PATENT GMBH (DE) 2023-06-06 US disclosed
US-7534474-B2 Multireactive polymerizable mesogenic compounds MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2009-05-19 US disclosed
US-7452575-B2 Liquid crystal medium and liquid crystal display with a highly twisted structure MERCK PATENT GMBH (DE) 2008-11-18 US disclosed
US-7452575-B2 Liquid crystal medium and liquid crystal display with a highly twisted structure MERCK PATENT GMBH (DE) 2008-11-18 US disclosed
US-7443900-B2 Laser gain medium for solid state dye lasers BASF AKTIENGESELLSCHAFT (DE) 2008-10-28 US disclosed
US-7440160-B2 Electro-optical light modulating element, electro-optical display and modulating medium MERCK PATENT GMBH (DE) 2008-10-21 US disclosed
US-7318950-B2 Chiral compounds II MERCK GMBH (DE) 2008-01-15 US disclosed
US-7318950-B2 Chiral compounds II MERCK GMBH (DE) 2008-01-15 US disclosed
EP-1299335-B1 CHIRAL COMPOUNDS II MERCK PATENT GMBH (DE) 2007-09-05 EP disclosed
US-7252785-B2 Composition of a radiation-absorbing tert-alkylphenoxy-substituted polycyclic ccmpound and a curable IR-reflecting component of achiral nematic polymerizable monomer, a chiral polymerizable monomer, a cholesteric polymerizable monomer, and a cholesteric polymer in a polymerizable diluent BASF AKTIENGESELLSCHAFT (DE) 2007-08-07 US disclosed
US-20070009675-A1 Multireactive polymerizable mesogenic compounds FARRAND LOUISE 2007-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667840-B2 Liquid-crystalline medium FES, BLM, CXCL12 ALDH1A1 3893/4885BCHE 4215/4885MAPT 2826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.